Real-World Data Evaluating Outcomes Following Neoadjuvant and Adjuvant Therapy in Patients with HER2-Positive Early Breast Cancer Ana-Marija Bukovica Petrc1,2, Marin Golcic1,2, Doris Kolovrat1,2, Tijaha Salopek1, Alojzije Kosic1,2, Iva Skocilic1,2, Anita Beg1, Sanja Ropac1, Maja Kolak1 and Ivana Mikolasevic1,2